1
TITLE: Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States
AUTHORS: Munir, T; Genovez, V; Genestier, V; Ryan, K; Liljas, B; Gaitonde, P;
PUBLISHED: 2023, SOURCE: Expert Review of Pharmacoeconomics and Outcomes Research
INDEXED IN: Scopus